Drug Trials Snapshots: QULIPTA (atogepant)

Drug Trials Snapshots: QULIPTA (atogepant)(atogepant) https://www.fda.gov/drugs/drug-approvals-and-databases/drug-trials-snapshots-qulipta QULIPTA is a drug used daily for the preventive treatment of episodic migraine (with headaches occurring up to 14 days per month) in adults. A migraine is a type of headache that can be associated with nausea, vomiting, and/or sensitivity to light or sound.